Lenat Joffe1, Sarah Dwyer2, Julia L Glade Bender3, A Lindsay Frazier4, Elena J Ladas5. 1. Department of Pediatric Hematology, Oncology and Stem Cell Transplant, Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York. 2. Institute of Human Nutrition, Columbia University Medical Center, New York, New York. 3. Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York. 4. Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts. 5. Department of Pediatric Hematology, Oncology and Stem Cell Transplant, Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York. Electronic address: ejd14@cumc.columbia.edu.
Abstract
INTRODUCTION: Nutritional status (NS), defined by undernutrition (body mass index [BMI] <5th percentile) or overnutrition (BMI ≥ 85th percentile), is a poor prognostic indicator in pediatric oncology patients. The impact of NS has been primarily studied in hematologic malignancies. This review is intended to summarize literature reporting on the association of NS and treatment-related outcomes in pediatric solid tumors. METHODS: We searched four electronic databases from inception through August 2018 without language restriction, and included studies of children with cancers arising from renal, bone, liver, eye, muscle, vascular, germ cell, and neural crest tissues, reporting on NS as a predictor for toxicity, survival or relapse. Due to data heterogeneity and limited availability of studies, formal statistical analysis was not achievable. Descriptive statistics were summarized in table format. RESULTS: Of 8,991 reports identified, 75 full-text articles were evaluated, 10 of which met inclusion criteria. Up to 62% of patients were over- or undernourished at diagnosis. Abnormal BMI was associated with worse overall survival in Ewing sarcoma (hazard ratio (HR): 3.46, P = .022), osteosarcoma (HR: 1.6, P < .005), and a trend toward poorer overall survival in rhabdomyosarcoma (HR: 1.70, P = .0596). High BMI in osteosarcoma was associated with increased nephrotoxicity (odds ratio: 2.8, P = .01) and postoperative complications. NS was not a significant predictor of outcomes in other included disease categories. CONCLUSIONS: Existing literature supports the prognostic significance of NS in pediatric solid tumor patients and underscores the need for prospective studies to better elucidate underlying physiological changes in this population.
INTRODUCTION: Nutritional status (NS), defined by undernutrition (body mass index [BMI] <5th percentile) or overnutrition (BMI ≥ 85th percentile), is a poor prognostic indicator in pediatric oncology patients. The impact of NS has been primarily studied in hematologic malignancies. This review is intended to summarize literature reporting on the association of NS and treatment-related outcomes in pediatric solid tumors. METHODS: We searched four electronic databases from inception through August 2018 without language restriction, and included studies of children with cancers arising from renal, bone, liver, eye, muscle, vascular, germ cell, and neural crest tissues, reporting on NS as a predictor for toxicity, survival or relapse. Due to data heterogeneity and limited availability of studies, formal statistical analysis was not achievable. Descriptive statistics were summarized in table format. RESULTS: Of 8,991 reports identified, 75 full-text articles were evaluated, 10 of which met inclusion criteria. Up to 62% of patients were over- or undernourished at diagnosis. Abnormal BMI was associated with worse overall survival in Ewing sarcoma (hazard ratio (HR): 3.46, P = .022), osteosarcoma (HR: 1.6, P < .005), and a trend toward poorer overall survival in rhabdomyosarcoma (HR: 1.70, P = .0596). High BMI in osteosarcoma was associated with increased nephrotoxicity (odds ratio: 2.8, P = .01) and postoperative complications. NS was not a significant predictor of outcomes in other included disease categories. CONCLUSIONS: Existing literature supports the prognostic significance of NS in pediatric solid tumorpatients and underscores the need for prospective studies to better elucidate underlying physiological changes in this population.
Authors: Jennifer A Ligibel; Catherine M Alfano; Dawn L Hershman; Janette K Merrill; Karen Basen-Engquist; Zachary T Bloomgarden; Wendy Demark-Wahnefried; Suzanne Dixon; Sandra G Hassink; John M Jakicic; John Magaña Morton; Tochi M Okwuosa; Tiffany M Powell-Wiley; Amy E Rothberg; Mark Stephens; Sarah E Streett; Robert A Wild; Eric A Westman; Ronald J Williams; Dana S Wollins; Clifford A Hudis Journal: Obesity (Silver Spring) Date: 2017-11 Impact factor: 5.002
Authors: Jeremy M Sharib; Jobin Cyrus; Andrew Horvai; Florette K Gray Hazard; John Neuhaus; Katherine K Matthay; Robert Goldsby; Neyssa Marina; Steven G DuBois Journal: Pediatr Blood Cancer Date: 2011-12-16 Impact factor: 3.167
Authors: Christopher J C Marriott; Lesley F Beaumont; Troy H Farncombe; Amy N Cranston; Uma H Athale; Valerie N Yakemchuk; Colin E Webber; Ronald D Barr Journal: Cancer Date: 2017-12-12 Impact factor: 6.860
Authors: Malcolm A Smith; Nita L Seibel; Sean F Altekruse; Lynn A G Ries; Danielle L Melbert; Maura O'Leary; Franklin O Smith; Gregory H Reaman Journal: J Clin Oncol Date: 2010-04-19 Impact factor: 44.544
Authors: David A Rodeberg; Julie A Stoner; Norbert Garcia-Henriquez; R Lor Randall; Sheri L Spunt; Carola A Arndt; Simon Kao; Charles N Paidas; Lynn Million; Douglas S Hawkins Journal: Cancer Date: 2010-12-14 Impact factor: 6.860
Authors: Nguyen K Tram; Ting-Heng Chou; Laila N Ettefagh; Kyra Deep; Adam J Bobbey; Anthony N Audino; Mitchel R Stacy Journal: Eur Radiol Date: 2022-08-10 Impact factor: 7.034